Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT07481708
PHASE1
A Clinical Study of the Effect of Enlicitide (MK-0616) Formulations in Healthy Participants (MK-0616-041)
Sponsor: Merck Sharp & Dohme LLC
View on ClinicalTrials.gov
Summary
The goal of this study is to learn what happens to enlicitide (MK-0616) in a healthy person's body over time (pharmacokinetic or PK study). Researchers also want to learn about the safety of enlicitide and if people tolerate it.
Official title: A Clinical Study to Evaluate the Relative Bioavailability of Enlicitide Tablet Formulations Compared to the Reference Formulation in Healthy Adult Participants
Key Details
Gender
All
Age Range
19 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2026-03-23
Completion Date
2026-05-25
Last Updated
2026-04-03
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
Enlicitide
Oral administration
Locations (1)
Celerion ( Site 0001)
Lincoln, Nebraska, United States